Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of February 2026, specifically dated February 9, 2026. The report serves to disclose a significant corporate governance event: the resignation of the Company's Chief Financial Officer.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
The primary material change disclosed is the resignation of Ronen Tsimmerman as Chief Financial Officer. The resignation is effective upon the appointment of a successor. The Company explicitly states that the departure is not related to any disagreement regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing references a press release noting Mr. Tsimmerman's nine years of service and key milestones achieved. No specific financial guidance, future outlook, or new risk factors are detailed in the text of this Form 6-K. The Company is in the process of appointing a successor to the CFO role.
Key Facts for Investor Verification
- Verify the timeline for the appointment of the new Chief Financial Officer.
- Review the full text of the press release (Exhibit 99.1) for details on the transition plan.
- Confirm that the resignation is amicable and unrelated to operational or financial disputes.
- Monitor subsequent filings for the appointment of the successor and any interim financial reporting arrangements.